Orgenesis Inc.
06/27/2024 | Press release | Distributed by Public on 06/27/2024 14:07
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 27, 2024, Orgenesis Inc. (the "Company") held its 2024 annual meeting of stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders approved an amendment to the 2017 Equity Incentive Plan (the "2017 Plan") to increase the number of shares available for the grant of awards by 9,000,000 shares. A detailed summary of the material features of the 2017 Plan is set forth in the Company's definitive proxy statement for the Annual Meeting (the "Proxy Statement") filed with the Securities and Exchange Commission (the "SEC") on May 6, 2024. That summary and the foregoing description is qualified in its entirety by reference to the text of the 2017 Plan, as amended, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.As previously disclosed in the Proxy Statement, each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024. The decision of each of Mr. Yachin, Dr. Sidransky and Mr. Philips not to stand for re-election was not the result of any disagreement between the Company and themselves on any matter relating to the Company's operations, policies or practices.